Loading organizations...
Loading organizations...
Developer of genetically defined therapies for neurological diseases.
SwanBio Therapeutics has raised $108.0M across 2 funding rounds.
SwanBio Therapeutics has raised $108.0M in total across 2 funding rounds.
SwanBio Therapeutics has raised $108.0M in total across 2 funding rounds.
SwanBio Therapeutics's investors include Mass General Brigham Ventures, Chris Hollowood, Partners Innovation Fund, Syncona.
SwanBio Therapeutics has raised $108.0M across 2 funding rounds. Most recently, it raised $56.0M Series B in May 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 18, 2022 | $56.0M Series B | Mass General Brigham Ventures, Chris Hollowood | |
| Apr 24, 2020 | $52.0M Series A Extension | Partners Innovation Fund, Syncona |